abrdn Life Sciences Investors
HQL
74 hedge funds and large institutions have $149M invested in abrdn Life Sciences Investors in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 11 closing their positions.
9% more capital invested
Capital invested by funds: $136M → $149M (+$12.5M)
0.98% more ownership
Funds ownership: 35.17% → 36.15% (+0.98%)
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
1% less funds holding
Funds holding: 75 → 74 (-1)
29% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 28
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Penserra Capital Management
Orinda,
California
|
+$11.7M |
| 2 |
SIA
Sit Investment Associates
Minneapolis,
Minnesota
|
+$3.4M |
| 3 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$972K |
| 4 |
WAM
WNY Asset Management
Williamsville,
New York
|
+$320K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$228K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RL
RPO LLC
Stamford,
Connecticut
|
-$3.67M |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$1.65M |
| 3 |
AW
Atlas Wealth
Cincinnati,
Ohio
|
-$1.19M |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$1.12M |
| 5 |
1CP
1607 Capital Partners
Richmond,
Virginia
|
-$1.06M |
HQL Hedge Fund Activity: Q3 2024 in Review
74 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2024, worth a combined $149M — up 9.2% from $136M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of HQL and 10 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 20 added.
The largest buyer was Penserra Capital Management, opening a new position worth an estimated $11.7M. The largest seller was RPO LLC, exiting entirely with an estimated $3.67M sold.
- 74 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2024, down from 75 in Q2 2024.
- Funds reported $149M of abrdn Life Sciences Investors stock for Q3 2024, up 9.2% quarter-over-quarter.
- 10 funds opened new abrdn Life Sciences Investors positions in Q3 2024 and 11 closed out, a net change of -1 holder.
- The largest abrdn Life Sciences Investors buyer in Q3 2024 was Penserra Capital Management, an estimated $11.7M added.
- The largest abrdn Life Sciences Investors seller in Q3 2024 was RPO LLC, an estimated $3.67M sold.
Based on aggregated 13F filings for Q3 2024.